NEW YORK (GenomeWeb) – Genetic Technologies and Swisstec today announced a deal to finalize a joint venture to create a new company.

The new company will enable GTG and Swisstec to develop a service platform using blockchain technology for medical services and personalized health management, the partners said, adding the JV will facilitate data management and AI-based services to improve health outcomes.